Patient cases on migraine prophylaxis: beta-blockers, antiseizure medications, CGRP monoclonal antibodies (mAbs), role of shared decision-making
Patient cases on comorbidities in migraine, including sleep disorders, depression, and more
Expert commentary on new monoclonal antibodies that target CGRP for the prevention of chronic migraine from CCO
Expert commentary from CCO on the evolving management of acute and preventive migraine treatment and the promise of anti-CGRP therapies
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.